| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/542 |
| P953 | full work available online at | http://www.nature.com/articles/ng0698_175 |
| http://www.nature.com/articles/ng0698_175.pdf | ||
| P3181 | OpenCitations bibliographic resource ID | 2198301 |
| P698 | PubMed publication ID | 9620776 |
| P50 | author | Thanos D Halazonetis | Q88944552 |
| P2093 | author name string | E. S. Stavridi | |
| J. L. Waterman | |||
| M. J. Waterman | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Mdm2 promotes the rapid degradation of p53 | Q24322597 | ||
| Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine | Q24322674 | ||
| A single ataxia telangiectasia gene with a product similar to PI-3 kinase | Q24323579 | ||
| UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells | Q24609948 | ||
| Regulation of p53 stability by Mdm2 | Q27860744 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Mitotic and G 2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216 | Q28247771 | ||
| DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 | Q28254119 | ||
| 14-3-3sigma is a p53-regulated inhibitor of G2/M progression | Q28276061 | ||
| The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding | Q28639955 | ||
| The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity | Q29547190 | ||
| A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | Q29615437 | ||
| p53 is required for radiation-induced apoptosis in mouse thymocytes | Q29620281 | ||
| DNA damage induces phosphorylation of the amino terminus of p53 | Q35199554 | ||
| Wild-type p53 is a cell cycle checkpoint determinant following irradiation | Q37152060 | ||
| Regulation of the specific DNA binding function of p53 | Q38324290 | ||
| p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle | Q40022281 | ||
| Apoptosis in cancer therapy: crossing the threshold | Q40694262 | ||
| Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA. | Q40872252 | ||
| Structural aspects of the p53 protein in relation to gene evolution: a second look. | Q41034333 | ||
| Three distinct signalling responses by murine fibroblasts to genotoxic stress | Q42807014 | ||
| 14-3-3 and its possible role in co-ordinating multiple signalling pathways | Q47986680 | ||
| 14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast | Q48080836 | ||
| Thymocyte apoptosis induced by p53-dependent and independent pathways | Q54242475 | ||
| p53 status and the efficacy of cancer therapy in vivo | Q72839445 | ||
| The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate | Q73433534 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 175-8 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins | |
| P478 | volume | 19 |
| Q42085579 | 14-3-3 (Bmh) Proteins Inhibit Transcription Activation by Adr1 through Direct Binding to Its Regulatory Domain |
| Q35879488 | 14-3-3 Proteins--a focus on cancer and human disease |
| Q34439988 | 14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation |
| Q24315405 | 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers |
| Q33951080 | 14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation |
| Q36100873 | 14-3-3 checkpoint regulatory proteins interact specifically with DNA repair protein human exonuclease 1 (hEXO1) via a semi-conserved motif |
| Q41887944 | 14-3-3 interaction with histone H3 involves a dual modification pattern of phosphoacetylation. |
| Q36159291 | 14-3-3 protein signaling in development and growth factor responses. |
| Q28512082 | 14-3-3 proteins integrate E2F activity with the DNA damage response. |
| Q37501480 | 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response |
| Q35841994 | 14-3-3 proteins: a number of functions for a numbered protein |
| Q34400246 | 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. |
| Q34405540 | 14-3-3 proteins; bringing new definitions to scaffolding |
| Q38362716 | 14-3-3sigma is a cruciform DNA binding protein and associates in vivo with origins of DNA replication |
| Q40547508 | 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation |
| Q24531933 | 14-3-3zeta interacts with the alpha-chain of human interleukin 9 receptor |
| Q38316168 | 14-3-3ζ interacts with hepatocyte nuclear factor 1α and enhances its DNA binding and transcriptional activation |
| Q36549508 | 14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth |
| Q50063897 | 15N detection harnesses the slow relaxation property of nitrogen: Delivering enhanced resolution for intrinsically disordered proteins |
| Q28203791 | A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1 |
| Q34352878 | A decade of site- and phosphorylation state-specific antibodies: recent advances in studies of spatiotemporal protein phosphorylation |
| Q33695618 | A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function |
| Q37523583 | A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis |
| Q22008733 | A role for ATR in the DNA damage-induced phosphorylation of p53 |
| Q34572898 | A role for p53 in the frequency and mechanism of mutation |
| Q35210961 | A unique four-hub protein cluster associates to glioblastoma progression. |
| Q28143424 | ATM and ATR: networking cellular responses to DNA damage |
| Q35625983 | ATM and ATR: sensing DNA damage. |
| Q29547735 | ATM and related protein kinases: safeguarding genome integrity |
| Q30175960 | ATM associates with and phosphorylates p53: mapping the region of interaction |
| Q30308300 | ATM-dependent Dissociation of B55 Regulatory Subunit from Nuclear PP2A in Response to Ionizing Radiation |
| Q33771767 | ATM: a mediator of multiple responses to genotoxic stress |
| Q35132648 | ATM: sounding the double-strand break alarm |
| Q77534913 | ATM: the p53 booster |
| Q33722965 | ATM: the product of the gene mutated in ataxia-telangiectasia |
| Q28366563 | Activation and activities of the p53 tumour suppressor protein |
| Q50318352 | Activation of ATM-dependent DNA damage signal pathway by a histone deacetylase inhibitor, trichostatin A. |
| Q44156173 | Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. |
| Q40613054 | Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2. |
| Q34605518 | Activation of the p53 tumor suppressor protein |
| Q33964757 | Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF. |
| Q35553620 | Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ∆133p53α mimic |
| Q45868414 | Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors |
| Q34490992 | Apoptotic proteins. p53 and c-myc related pathways |
| Q39476200 | Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase |
| Q34087750 | Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. |
| Q33697357 | Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene |
| Q28508555 | Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system |
| Q28117267 | BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites |
| Q27934213 | Binding and transcriptional regulation by 14-3-3 (Bmh) proteins requires residues outside of the canonical motif |
| Q55033490 | Binding of 14-3-3 protein to the plasma membrane H(+)-ATPase AHA2 involves the three C-terminal residues Tyr(946)-Thr-Val and requires phosphorylation of Thr(947). |
| Q39918674 | Bioinformatic and experimental survey of 14-3-3-binding sites. |
| Q35752270 | Biophysical Characterization of Essential Phosphorylation at the Flexible C-Terminal Region of C-Raf with 14-3-3ζ Protein. |
| Q28374816 | Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells |
| Q43821044 | Camptothecin and Zeocin Can Increase p53 Levels during All Cell Cycle Stages |
| Q36627909 | Candidate protein biodosimeters of human exposure to ionizing radiation. |
| Q28609768 | Cdk5 phosphorylates p53 and regulates its activity |
| Q22008792 | Cell adhesion regulates the interaction between the docking protein p130(Cas) and the 14-3-3 proteins |
| Q28201863 | Cell cycle regulation and p53 activation by protein phosphatase 2C alpha |
| Q37177493 | Cellular adaptation to hypoxia and p53 transcription regulation |
| Q42847208 | Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions |
| Q27678611 | Characterization of 14-3-3-ζ Interactions with Integrin Tails |
| Q56602132 | Checkpoints: How to activate p53 |
| Q24610106 | Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53 |
| Q28363906 | Cisplatinum and taxol induce different patterns of p53 phosphorylation |
| Q34011009 | Controlling the Mdm2-Mdmx-p53 Circuit |
| Q40902845 | Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation |
| Q43002029 | Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells. |
| Q40960693 | Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. |
| Q39061971 | Cyclic nucleotide dependent dephosphorylation of regulator of G-protein signaling 18 in human platelets. |
| Q34718342 | Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets. |
| Q33814324 | DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis |
| Q24338364 | DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation |
| Q73434282 | DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo |
| Q40960688 | DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization |
| Q58134191 | DNA damage‐inducible phosphorylation of p53 at Ser20 is required for p53 stabilization |
| Q73270718 | Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation |
| Q44487712 | Dephosphorylation of p53 during cell death by N-alpha-tosyl-L-phenylalanyl chloromethyl ketone |
| Q28567929 | Diabetes-induced oxidative DNA damage alters p53-p21CIP1/Waf1 signaling in the rat testis |
| Q33997846 | Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress |
| Q24291896 | Differential Effect of ik3-1/Cables on p53- and p73-induced Cell Death |
| Q36005292 | Differential functions of 14-3-3 isoforms in vertebrate development |
| Q35071233 | Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage. |
| Q28200031 | Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression |
| Q74088930 | Distinct pattern of p53 phosphorylation in human tumors |
| Q33957610 | Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53 |
| Q35787179 | Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. |
| Q34602367 | Dynamic multiprotein assemblies shape the spatial structure of cell signaling |
| Q34097322 | Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta |
| Q36594912 | Endoplasmic reticulum stress and apoptosis. |
| Q24306430 | Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta |
| Q95297226 | Energization of plant cell membranes by H+-pumping ATPases. Regulation and biosynthesis |
| Q38306307 | Epidermal growth factor sensitizes cells to ionizing radiation by down-regulating protein mutated in ataxia-telangiectasia. |
| Q42716666 | Epigenetic activation of Sox2 gene in the developing vertebrate neural plate |
| Q33288665 | Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment |
| Q44515894 | Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex |
| Q37428803 | Extensive post-translational modification of active and inactivated forms of endogenous p53. |
| Q39024822 | Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation |
| Q30936349 | Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. |
| Q43649352 | Functional analysis and intracellular localization of p53 modified by SUMO-1. |
| Q33863075 | Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity |
| Q35040486 | Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants |
| Q35268497 | Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study |
| Q33834966 | Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53. |
| Q35027110 | Genetic networks in the mouse retina: growth associated protein 43 and phosphatase tensin homolog network |
| Q34417108 | Genotoxic and non-genotoxic pathways of p53 induction |
| Q36756441 | Glucose-mediated transactivation of carbohydrate response element-binding protein requires cooperative actions from Mondo conserved regions and essential trans-acting factor 14-3-3 |
| Q38309880 | Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability |
| Q40755915 | Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants |
| Q52548175 | Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract |
| Q28646561 | Homologous recombinational repair of DNA ensures mammalian chromosome stability |
| Q34120299 | How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis |
| Q36879036 | How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? |
| Q35772958 | Human papillomavirus 18 E6 inhibits phosphorylation of p53 expressed in HeLa cells. |
| Q40053731 | IDENTIFICATION AND EXPRESSION ANALYSIS OF TWO 14-3-3 PROTEINS IN THE MOSQUITO Aedes aegypti, AN IMPORTANT ARBOVIRUSES VECTOR. |
| Q27661215 | Identification and structure of small-molecule stabilizers of 14-3-3 protein-protein interactions |
| Q38795536 | Identification of 14-3-3zeta associated protein networks in oral cancer |
| Q37212448 | Identification of new p53 acetylation sites in COS-1 cells |
| Q40821486 | Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner |
| Q36738823 | Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals |
| Q34147089 | Initiation of eukaryotic DNA replication: regulation and mechanisms |
| Q34425447 | Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling |
| Q30433273 | Insulin-stimulated interaction with 14-3-3 promotes cytoplasmic localization of lipin-1 in adipocytes |
| Q30309867 | Ionizing radiation activates nuclear protein phosphatase-1 by ATM-dependent dephosphorylation |
| Q38317558 | Isolation and characterization of Xenopus ATM (X-ATM): expression, localization, and complex formation during oogenesis and early development |
| Q44212272 | Kainic acid induces 14-3-3 zeta expression in distinct regions of rat brain |
| Q33558659 | Kinetics of p53 binding to promoter sites in vivo |
| Q24304413 | MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1 |
| Q73098723 | Many faces of ATM: eighth international workshop on ataxia-telangiectasia |
| Q35849887 | Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia |
| Q33807813 | Mechanisms of switching on p53: a role for covalent modification? |
| Q24319736 | Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms |
| Q35040499 | Metabolic enzymes as targets for 14-3-3 proteins |
| Q33798868 | Metal ions as regulators of the conformation and function of the tumour suppressor protein p53: implications for carcinogenesis. |
| Q40103473 | Methylation-acetylation interplay activates p53 in response to DNA damage |
| Q90341376 | Modeling the role of microRNA-449a in the regulation of the G2/M cell cycle checkpoint in prostate LNCaP cells under ionizing radiation |
| Q45302322 | Modifications of p53 and the DNA Damage Response in Cells Expressing Mutant Form of the Protein Huntingtin |
| Q22254010 | Modulation of human DNA topoisomerase IIalpha function by interaction with 14-3-3epsilon |
| Q33704559 | Molecular interaction map of the mammalian cell cycle control and DNA repair systems |
| Q33854461 | Molecular mechanisms in myelodysplastic syndromes and implications for evolution to acute leukemias. |
| Q44279213 | Monomeric 14-3-3 protein is sufficient to modulate the activity of the Drosophila slowpoke calcium-dependent potassium channel |
| Q35018012 | Multisite phosphorylation provides sophisticated regulation of transcription factors |
| Q33818479 | Mutant TP53 posttranslational modifications: challenges and opportunities. |
| Q34657712 | Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair |
| Q24337056 | NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner |
| Q45856234 | New p53-based anti-cancer therapeutic strategies |
| Q33707289 | Nijmegen breakage syndrome: consequences of defective DNA double strand break repair |
| Q40938040 | Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers |
| Q40795415 | PEAZ-1: a new human prostate neoplastic epithelial cell line |
| Q38965830 | Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells |
| Q36012544 | Phosphorylation at carboxyl-terminal S373 and S375 residues and 14-3-3 binding are not required for mouse p53 function |
| Q28609754 | Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage |
| Q73283484 | Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification |
| Q40810916 | Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV. |
| Q24322729 | Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression |
| Q44513266 | Phosphorylation site interdependence of human p53 post-translational modifications in response to stress |
| Q24337479 | Phosphorylation-dependent regulation of SCFFbx4 dimerization and activity involves a novel component, 14-3-3ɛ |
| Q34114100 | Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function |
| Q33605918 | Polarity proteins and cell-cell interactions in the testis |
| Q34054886 | Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. |
| Q35930703 | Post-translational modification of p53 in tumorigenesis |
| Q39452086 | Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage |
| Q36527456 | Posttranslational phosphorylation of mutant p53 protein in tumor development |
| Q34263570 | Preparation and application of antibodies to phosphoamino acid sequences |
| Q24299787 | Protein kinase A phosphorylates and regulates dimerization of 14-3-3 epsilon |
| Q34249076 | Protein modifications regulate the role of 14-3-3γ adaptor protein in cAMP-induced steroidogenesis in MA-10 Leydig cells. |
| Q24675387 | Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein |
| Q42109676 | Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice |
| Q36777971 | Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage |
| Q55282001 | Recent advances in understanding oogenesis: interactions with the cytoskeleton, microtubule organization, and meiotic spindle assembly in oocytes. |
| Q24321733 | Recognition of an intra-chain tandem 14-3-3 binding site within PKCepsilon |
| Q28214575 | Recombinational DNA repair and human disease |
| Q33800722 | Redox signalling and transition metals in the control of the p53 pathway |
| Q74189456 | Refolding and structural characterization of the human p53 tumor suppressor protein |
| Q33828413 | Regulation of MCP-1 chemokine transcription by p53 |
| Q24306287 | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. |
| Q40346478 | Regulation of p53 by activated protein kinase C-delta during nitric oxide-induced dopaminergic cell death |
| Q24554530 | Regulation of p53 function and stability by phosphorylation |
| Q33807801 | Regulation of p53 in response to DNA damage |
| Q35116637 | Regulation of p53 responses by post-translational modifications |
| Q39978322 | Regulation of p53 target gene expression by peptidylarginine deiminase 4 |
| Q37636014 | Regulation of p53--insights into a complex process |
| Q43657451 | Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation |
| Q27940266 | Regulation of yeast Yak1 kinase by PKA and autophosphorylation-dependent 14-3-3 binding |
| Q40581778 | Rep68 protein of adeno-associated virus type 2 interacts with 14-3-3 proteins depending on phosphorylation at serine 535. |
| Q33957738 | Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks |
| Q42055057 | Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding |
| Q39047050 | Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells |
| Q39555703 | SMG7 is a critical regulator of p53 stability and function in DNA damage stress response. |
| Q43915766 | SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression |
| Q40470745 | Safrole oxide induces apoptosis in A549 human lung cancer cells. |
| Q33920071 | Sensing core histone phosphorylation - a matter of perfect timing. |
| Q77430977 | Signaling to p53: breaking the MDM2-p53 circuit |
| Q33800384 | Single-nucleotide polymorphisms in the p53 signaling pathway. |
| Q42832053 | Specific pattern of p53 phosphorylation during nitric oxide-induced cell cycle arrest |
| Q33961679 | Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization |
| Q34076012 | Strategies for manipulating the p53 pathway in the treatment of human cancer. |
| Q24301745 | Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer |
| Q40297096 | Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression |
| Q35967111 | Surf the post-translational modification network of p53 regulation |
| Q74200551 | Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways |
| Q37685118 | Systems-wide proteomic characterization of combinatorial post-translational modification patterns |
| Q24290626 | TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins |
| Q91738289 | TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer |
| Q40700411 | Temperature-sensitive ovarian carcinoma cell line (OvBH-1). |
| Q35635340 | The 14-3-3 cancer connection |
| Q33892835 | The ATM gene and breast cancer: is it really a risk factor? |
| Q35132636 | The DNA damage checkpoint and human cancer |
| Q59360168 | The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity |
| Q42055738 | The N terminus of p53 regulates its dissociation from DNA. |
| Q33632328 | The PIK-related kinases intercept conventional signaling pathways |
| Q33771774 | The cellular response to p53: the decision between life and death |
| Q35885867 | The centrosome in higher organisms: structure, composition, and duplication |
| Q28284854 | The complexity of p53 modulation: emerging patterns from divergent signals |
| Q36443523 | The complexity of p53 stabilization and activation |
| Q73816403 | The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase |
| Q34568581 | The diversity of p53 mutations among human brain tumors and their functional consequences. |
| Q89144664 | The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions |
| Q34487385 | The evolution of diverse biological responses to DNA damage: insights from yeast and p53 |
| Q27863460 | The genetics of the p53 pathway, apoptosis and cancer therapy |
| Q37596345 | The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption |
| Q53389191 | The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. |
| Q33738458 | The p53 pathway and apoptosis |
| Q34187832 | The p53 tumour suppressor protein |
| Q28206425 | The processing of Holliday junctions by BLM and WRN helicases is regulated by p53 |
| Q37800755 | The relevance of protein-protein interactions for p53 function: the CPE contribution. |
| Q38327777 | The time-dependent serial gene response to Zeocin treatment involves caspase-dependent apoptosis in HeLa cells |
| Q34786668 | Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity |
| Q37733013 | Tuning the electrical properties of the heart by differential trafficking of KATP ion channel complexes |
| Q34699448 | Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma |
| Q64236647 | Understanding p53 functions through p53 antibodies |
| Q37649607 | Unreported intrinsic disorder in proteins: Building connections to the literature on IDPs |
| Q30868748 | Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. |
| Q42800244 | c-abl is involved in the association of p53 and trk A. |
| Q35787253 | cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia |
| Q33734522 | p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. |
| Q36088355 | p53 RNA interactions: new clues in an old mystery |
| Q43583412 | p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling |
| Q34388165 | p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation |
| Q91701515 | p53 modifications: exquisite decorations of the powerful guardian |
| Q33807807 | p53 regulation by post-translational modification and nuclear retention in response to diverse stresses |
| Q36997572 | p53 regulation upon genotoxic stress: intricacies and complexities |
| Q77954392 | p53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts |
| Q74083357 | p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53 |
| Q34305233 | p53-dependent apoptosis pathways. |
| Q36028209 | p53: traffic cop at the crossroads of DNA repair and recombination |
Search more.